Search
forResearch 10 of 30
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Emerging medication for the treatment of male hypogonadism
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Androgen receptor: A promising therapeutic target in breast cancer
- Anabolic-androgenic steroids. Mechanism of action and clinical effects
- Impact of estrogens in males and androgens in females
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →